
Since 1991, Ravimed has been manufacturing containers for blood collection, storage and processing with solutions for blood preservation for therapeutic purposes, which constitute a closed system for the optimum use of blood and its components.
Sets of containers for blood collection, storage and processing with solution for blood preservation are intended, depending on their configuration, for the following:
- single
- full blood collection and storage;
- double
- full blood division into two parts
- separation of red blood cells from plasma
- triple
- full blood division into three parts
- blood division into red blood cells, platelets and plasma
- quadruple
- full blood division into four parts
- blood division into red blood cells, leukocytes, platelets and plasma;
- fivefold
- full blood division into four parts
- blood division into red blood cells, leukocytes, platelets and plasma;
- six fold
- full blood division into four parts
- blood division into red blood cells, leukocytes, platelets and plasma;
- double plasmapharesis
- to acquire plasma through the separation of red blood cells from plasma and return them to the donor.
Blood fixatives (anticoagulants) and blood enriching liquids may contain Citric acid, sodium citrate, sodium phosphate, glucose, adenin, sodium citrate and mannitol:
- ACD-A – Acid citric, Citrate, Dextrose (glucose);
- CPDA-1 – Citrate, Phosphate, Dextrose, Adenine,
- CPD – Citrate, Phosphate, Dextrose,
- SAGM – Saline (Sodium chloride), Adenine, Glucose, Mannitol;
and ensure anticoagulation of the full blood and its storage for:
- CPD – 21 days
- CPDA-1 – 35 days
- SAGM – 42 days
Optionally, depending on their intended use, sets of containers are equipped with the following:
- casing which enables the protection of the needle after blood collection (protector)
- adapter which enables the collection of blood samples (undiluted with the fixative) during donation
- empty (transfer) container with a steel or plastic needle („Spike”)
- filter for leukocyte reduction
Filter type
Type of housing
Destination
Recommended blood filtration conditions
Necessity to store at 4 ° C before filtration
Average filtration time
Efficiency of filtration to the level
Type 402
Soft
Reduction of leukocytes
Blood of heat , 20-24 °C
Not required
25-30 min
<1.0 x 10 E6
Type 502
Soft
Reduction of erythrocytes
Blood of heat , 20-24 °C
<1 hour
25-30 min
<5.0 x 10 E6
Address
Zakład Produkcji Sprzętu Medycznego
RAVIMED Sp. z o.o.
ul. Polna 54
05-119 ŁajskiREGON:002027813, NIP: 531-000-41-18
KRS: 0000185727, K.Z. 50.000,- PLN
BDO: 000043116Contact data
Phone No.: +48 (22) 506 56 56+48 602 587 656Tel/fax: +48 (22) 782 21 67E-mail: ravimed@ravimed.com.plSales: +48 (22) 782 21 67 ext. 111Undesirable effects of medicinal products
E-mail: adr_ravimed@ravimed.com.pl
Tel: +48 (22) 782 21 67
+48 (22) 506 56 56
Fax: +48 (22) 782 21 67